Log in to your Inderes Free account to see all free content on this page.
Bio-Works Technologies
2.83 SEK
+6.39 %
Less than 1K followers
BIOWKS
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+6.39 %
+8.02 %
+26.34 %
+21.98 %
+48.95 %
+185.89 %
-81.91 %
-56.84 %
-67.07 %
Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.
Read moreMarket cap
277.98M SEK
Turnover
540.59K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.2.
2026
Annual report '25
4.6.
2026
General meeting '26
All
Press releases
ShowingAll content types
Bio-Works Technologies AB: Business Update
Bio-Works Technologies AB: Bio-Works Receives Two WorkBeads 100S and 100Q Orders Worth SEK 4 Million
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio